Dorsey Wright & Associates Veracyte, Inc. Transaction History

Dorsey Wright & Associates

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 27, 2021	SELL	$44.47 - $81.38 $30,817 - $56,396	-693 Closed	0 $0
Q4 2020 Jan 28, 2021	BUY	$32.49 - $61.88 $5,620 - $10,705	173 Added 33.27%	693 $34,000
Q3 2020 Oct 28, 2020	SELL	$26.73 - $35.67 $4,624 - $6,170	-173 Reduced 24.96%	520 $17,000
Q1 2020 Apr 20, 2020	SELL	$16.13 - $30.17 $1,274 - $2,383	-79 Reduced 10.23%	693 $17,000
Q3 2019 Oct 31, 2019	BUY	$23.87 - $30.93 $47 - $61	2 Added 0.26%	772 $19,000
Q2 2019 Jul 02, 2019	BUY	$22.1 - $28.56 $4,243 - $5,483	192 Added 33.22%	770 $22,000
Q1 2019 Apr 04, 2019	SELL	$12.0 - $25.76 $6,912 - $14,837	-576 Reduced 49.91%	578 $14,000
Q4 2018 Jan 07, 2019	BUY	$9.15 - $14.85 $10,559 - $17,136	1,154 New	1,154 $15,000

254

82.1M

42.3K

18.2K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.42B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.